
Consultant believed dispute over female changing rooms ‘was hate incident'
Sandie Peggie was suspended after she complained about having to share a changing room with transgender medic Dr Beth Upton at Victoria Hospital, Kircaldy, Fife, on Christmas Eve 2023.
She was placed on special leave after Dr Upton made an allegation of bullying and harassment and cited concerns about 'patient care'.
Ms Peggie has lodged a claim against NHS Fife and Dr Upton, citing the Equality Act 2010, including sexual harassment; harassment related to a protected belief; indirect discrimination; and victimisation.
The tribunal resumed in Dundee on July 16 after an initial set of hearings in February.
On Tuesday, Dr Kate Searle, a consultant in emergency medicine, said that Dr Upton was 'very open' about their trans status during a job interview, and had been out for around a year in August 2023, the tribunal heard.
Dr Searle said that she had known Ms Peggie during her 11-year career at NHS Fife but was unaware of her gender critical views, and had asked Dr Upton 'if she was happy using female changing rooms' in August 2023 during an induction and 'didn't make any other suggestions'.
She said she emailed equality lead Isla Bumba on December 8 2023 to ask if NHS Fife had a transgender policy but was told it did not.
Dr Searle said: 'I asked her if she was happy using female changing rooms, she said yes, I had nothing else to add.'
She said she emailed Ms Bumba as 'we've got our first transgender doctor working, there's very little information available', hoping there would be an NHS Fife policy on 'supporting transgender staff in their workplace', the tribunal heard.
On her return to work after Christmas, on December 29 2023, Dr Searle read an email from Dr Elspeth Pitt regarding an 'upsetting interaction with another member of staff' and an email from Dr Upton from Christmas Day, alleging Ms Peggie had told her 'she can't be in the female changing room, it's wrong and lots of others feel this way' and 'she continued to tell me she is intimidated, she told me women have a right to feel safe', and made a comment about 'prisons', the tribunal heard.
Dr Searle said: 'To me that was likening the situation to the Isla Bryson case that was very well publicised. Isla Bryson was a convicted rapist who was housed temporally in a female prison.'
She said she was 'very concerned' and 'knew there wasn't an NHS Fife policy', adding that 'according to the hate incident policy it is verbal harassment', the tribunal heard.
She said she had a meeting with Dr Upton at 5pm who was 'shaken and distressed', and they completed a Datix internal report together.
Dr Searle said: 'We looked at NHS Fife's hate incident policy and recognised this required a Datix to be completed, so we completed that together, we discussed reporting the incident to the police as that's again what is recommended in NHS Fife policy.
'Beth said she would think about it, we looked at her shift patterns to see when she was next due to be in and if she felt safe to do that.'
She added that Dr Upton 'mentioned two other incidents she had had with Sandie where she had felt the interaction was affected by Ms Peggie's feelings towards her as a transgender woman', and alleged that in one incident in a resuscitation unit 'Ms Peggie was doing nursing obs (observations) on a patient; when Beth walked in Ms Peggie left. Beth said 'do you want me to finish doing obs?', Ms Peggie said 'you can finish doing them yourself', and left the room', the tribunal heard.
She alleged that another incident involved a patient in a suspected mental health crisis leaving, and said that when Dr Upton went to look for Ms Peggie, the nurse 'would only speak to her through another member of nursing staff', the tribunal heard.
Dr Searle said: 'That would make me somewhat concerned for patient safety; in our team we need to communicate very well between ourselves to ensure patient safety.'
She said she had spoken to the healthcare worker, and added: 'I asked if she recalled the situation and she was concerned about getting involved in any discussions about the incident because she said 'I am mixed race and I am worried about getting involved in this for my own safety'.'
Counsel for both respondents, Jane Russell KC, said: 'What do you think she meant?'
Dr Searle said: 'This legal case where there is a lot of press attention and any staff being involved in the case have felt under scrutiny and concerned that their views will be widely publicised when they wouldn't otherwise.'
She said she completed the Datix as 'NHS staff must record all hate incidents' and added: 'We talked about reporting to the police, that's mentioned for hate incidents.'
The tribunal continues.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


South Wales Guardian
an hour ago
- South Wales Guardian
Pharmacies warn of unsustainable demand for weight loss medication
Many more patients are interested in using weight loss medication than are actually suitable for treatment, according to the National Pharmacy Association (NPA), which represents more than 6,000 independent community pharmacies. Some 21% of people who were interviewed in a NPA-commissioned poll agreed they had attempted to access weight loss treatments in the last year, either online or in person at a pharmacy, rising to 35% of 16 to 34-year-olds. This is compared to only 7% of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'


Times
an hour ago
- Times
I was a Gen Z screen addict. Then I took drastic action
A lot can happen in seven hours. You could fly from London to Dubai, get through a full school day or enjoy a luxurious night's sleep. Me? I used to spend seven hours a day staring at my phone screen. Now I average less than one. I'm 22 and I've spent an alarming percentage of my life glued to my phone. It was everything — my entertainment, my social lifeline, my procrastination tool, my 3am therapist. I'm far from alone. Data shows that Generation Z's daily screen time is on average more than nine hours a day, which is more than any other generation. That's about 136 days a year spent staring at a screen. Meanwhile, the NHS reports a steep rise in mental health disorders among young people, which tracks closely with the explosion in digital device use.

Leader Live
2 hours ago
- Leader Live
Pharmacies warn of unsustainable demand for weight loss medication
Many more patients are interested in using weight loss medication than are actually suitable for treatment, according to the National Pharmacy Association (NPA), which represents more than 6,000 independent community pharmacies. Some 21% of people who were interviewed in a NPA-commissioned poll agreed they had attempted to access weight loss treatments in the last year, either online or in person at a pharmacy, rising to 35% of 16 to 34-year-olds. This is compared to only 7% of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'